Atlas Venture Life Science Advisors, LLC Kymera Therapeutics, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $455 Million
- Q2 2025
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 4,896,462 shares of KYMR stock, worth $195 Million. This represents 47.0% of its overall portfolio holdings.
Number of Shares
4,896,462
Previous 4,896,462
-0.0%
Holding current value
$195 Million
Previous $134 Million
59.44%
% of portfolio
47.0%
Previous 39.25%
Shares
6 transactions
Others Institutions Holding KYMR
# of Institutions
217Shares Held
72.2MCall Options Held
178KPut Options Held
64.6K-
Price T Rowe Associates Inc Baltimore, MD6.86MShares$273 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.65MShares$265 Million2.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.56MShares$261 Million5.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$224 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.5MShares$219 Million9.44% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.18B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...